Effectiveness, safety and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in HIV-1 infected adult patients in routine clinical practice-6 months results of the BICSTaR cohort

被引：0

作者：

Esser, S. ^{[1
]}

Jessen, H. ^{[2
]}

Schneider, J. ^{[3
]}

Schellberg, S. ^{[4
]}

Stellbrink, H-J ^{[5
]}

Waizmann, M. ^{[6
]}

Hillenbrand, H. ^{[7
]}

Bilbao, P. ^{[8
]}

Schreiber, S. ^{[9
]}

Thorpe, D. ^{[8
]}

Ramroth, H. ^{[8
]}

Haubrich, R. ^{[10
]}

Heinzkill, M. ^{[9
]}

机构：

[1] Univ Hosp Essen, Clin Dermatol, Dept Venerol, Essen, Germany

[2] Praxis Jessen Kollegen, Berlin, Germany

[3] Tech Univ Munich, Sch Med, Univ Hosp Rechts Del Isar, Dept Med 2, Munich, Germany

[4] Novopraxis Berlin GbR, Berlin, Germany

[5] ICH Study Ctr, Hamburg, Germany

[6] Praxis Waizmann, Leipzig, Germany

[7] MVZ Praxis City Ost, Berlin, Germany

[8] Gilead Sci Europe Ltd, Uxbridge, Middx, England

[9] Gilead Sci GmbH, Munich, Germany

[10] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

来源：

HIV MEDICINE | 2019年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

PE2/16

引用

页码：61 / 61

页数：1

共 50 条

[41] Doravirine/Islatravir (100mg/0.75mg) once daily compared to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as Initial HIV-1 treatment: 48 week results from a double-blind phase 3 trial
Rockstroh, J. K.
Paredes, R.
Cahn, P.
Molina, J. -M.
Sokhela, S.
Hinestrosa, F.
Kassim, S.
Ortega, E. Valencia
Cunningham, D.
Ghosn, J.
Bogner, J. R.
Gatanaga, H.
Asante-Appiah, E.
Zang, Y.
Klopfer, S. O.
Eves, K.
Pisculli, M. L.
Squires, K.
Correll, T. A.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2023, 26
[42] Strategic simplification: the efficacy and safety of switching to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) plus darunavir (DRV) in treatment-experienced HIV-1 infected adults (NCT01968551)
Huhn, G.
Gallant, J.
Wilkin, T.
Callebaut, C.
Fordyce, M.
Das, M.
Mccallister, S.
Yau, S.
HIV MEDICINE, 2016, 17 : 15 - 15
[43] Patient-reported outcome (PRO) measures at 12 months (12M) in a real-world cohort of people living with HIV (PLWH) with a high prevalence of comorbidities receiving bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in Europe, Canada, and Israel
Brunetta, J.
Monforte, A. D'Arminio
Elbirt, D.
Postel, N.
van Welzen, B.
Zeggagh, J.
Milinkovic, A.
Marongiu, A.
Heinzkill, M.
Thorpe, D.
Cornejo, A. Torres
Antela, A.
HIV MEDICINE, 2021, 22 : 108 - 110
[44] Effectiveness, persistence and safety of E/C/F/TAF, F/TAF+3rd agent or R/F/TAF in treatment-experienced HIV-1 infected patients: 12-month results from the German TAFNES cohort study
Hillenbrand, H.
Knechten, H.
Kuemmerle, T.
Scholten, S.
Schuebel, N.
Haubrich, R.
Heinzkill, M.
Goerner, K.
Stellbrink, H.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
[45] Effectiveness, persistence and safety of E/C/F/TAF, F/TAF+3rd agent or R/F/TAF use in treatment-naive HIV-1 infected patients: 12-month results from the German TAFNES cohort study
Heuchel, T.
Hillenbrand, H.
Jessen, H.
Pauli, R.
Postel, N.
Haubrich, R.
Heinzkill, M.
Goerner, K.
Stellbrink, H.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
[46] Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNES cohort study
Stephan, Christoph
Spinner, Christoph D.
Rieke, Ansgar
Christensen, Stefan
Mauss, Stefan
Schreiber, Sandra
Albuquerque, Boris
Heinzkill, Marion
Ramroth, Heribert
Stellbrink, Hans-Juergen
HIV MEDICINE, 2025, 26 (02) : 239 - 251
[47] Efficacy and safety of the once-daily, darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) single-tablet regimen (STR) in ART-naive, HIV-1-infected adults: AMBER Week 96 results
Orkin, C.
Eron, J.
Rockstroh, J.
Podzamczer, D.
Esser, S.
Vandekerckhove, L.
Van Landuyt, E.
Lathouwers, E.
Hufkens, V.
Jezorwski, J.
Opsomer, M.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
[48] A phase 3b, open-label, pilot study to evaluate switching to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in virologically-suppressed HIV-1 infected adult subjects harboring NRTI resistance mutations M184V/I +/- TAMs (GS-US-292-1824): week 24 results
Perez-Valero, I.
Llibre, J. M.
Lazzarin, A.
Di Perri, G.
Pulido, F.
Molina, J-M
Esser, S.
Margot, N.
Shao, Y.
Piontkowsky, D.
Das, M.
McNicholl, I.
Haubrich, R.
HIV MEDICINE, 2019, 20 : 170 - 171
[49] Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1
Eron, Joseph J.
Orkin, Chloe
Cunningham, Douglas
Pulido, Federico
Post, Frank A.
De Wit, Stephane
Lathouwers, Erkki
Hufkens, Veerle
Jezorwski, John
Petrovic, Romana
Brown, Kimberley
Van Landuyt, Erika
Opsomer, Magda
De Wit, S.
Florence, E.
Moutschen, M.
Van Wijngaerden, E.
Vandekerckhove, L.
Vandercam, B.
Brunetta, J.
Conway, B.
Klein, M.
Murphy, D.
Rachlis, A.
Shafran, S.
Walmsley, S.
Ajana, F.
Cotte, L.
Girardy, P. -M.
Katlama, C.
Molina, J. -M.
Poizot-Martin, I.
Raffi, F.
Rey, D.
Reynes, J.
Teicher, E.
Yazdanpanah, Y.
Gasiorowski, J.
Halota, W.
Horban, A.
Piekarska, A.
Witor, A.
Arribas, J. R.
Perez-Valero, I.
Berenguer, J.
Casado, J.
Gatell, J. M.
Gutierrez, F.
Galindo, M. J.
Gutierrez, M. D. M.
ANTIVIRAL RESEARCH, 2019, 170
[50] A phase 3b, open-label, pilot study to evaluate switching to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in virologically-suppressed HIV-1 infected adult subjects harboring the NRTI resistance mutation M184V and/or M184I (GS-US-292-1824)
Valero, I. Perez
Llibre, J. M.
Lazzarin, A.
Di Perri, G.
Pulido, F.
Molina, J. -M.
Esser, S.
McNicholl, I.
Lorgeoux, R. -P.
Margot, N.
Shao, Y.
Piontkowsky, D.
Das, M.
Haubrich, R.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21 : 6 - 7

← 1 2 3 4 5 →